Literature DB >> 15864342

The role of hepatic insulin receptors in the regulation of glucose production.

Alan D Cherrington1.   

Abstract

The inability of insulin to suppress hepatic glucose production (HGP) is a key defect found in type 2 diabetes. Insulin inhibits HGP through both direct and indirect means, the latter of which include inhibition of glucagon secretion, reduction in plasma nonesterified fatty acid level, decrease in the load of gluconeogenic substrates reaching the liver, and change in neural signaling to the liver. Two studies in this issue of the JCI demonstrate that selective changes in the expression of insulin receptors in mouse liver do not have a detectable effect on the ability of insulin to inhibit HGP (see the related articles beginning on pages 1306 and 1314). These provocative data suggest that the indirect effects of insulin on the liver are the primary determinant of HGP in mice.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15864342      PMCID: PMC1087191          DOI: 10.1172/JCI25152

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  17 in total

1.  Basal hepatic glucose production is regulated by the portal vein insulin concentration.

Authors:  D K Sindelar; C A Chu; P Venson; E P Donahue; D W Neal; A D Cherrington
Journal:  Diabetes       Date:  1998-04       Impact factor: 9.461

Review 2.  The significance of intracellular insulin to insulin action.

Authors:  W C Duckworth; R G Bennett; F G Hamel
Journal:  J Investig Med       Date:  1997-02       Impact factor: 2.895

3.  Peripheral effects of insulin dominate suppression of fasting hepatic glucose production.

Authors:  M Ader; R N Bergman
Journal:  Am J Physiol       Date:  1990-06

4.  Insulin acts intracellularly on proteasomes through insulin-degrading enzyme.

Authors:  W C Duckworth; R G Bennett; F G Hamel
Journal:  Biochem Biophys Res Commun       Date:  1998-03-17       Impact factor: 3.575

5.  A comparison of the effects of selective increases in peripheral or portal insulin on hepatic glucose production in the conscious dog.

Authors:  D K Sindelar; J H Balcom; C A Chu; D W Neal; A D Cherrington
Journal:  Diabetes       Date:  1996-11       Impact factor: 9.461

6.  The role of fatty acids in mediating the effects of peripheral insulin on hepatic glucose production in the conscious dog.

Authors:  D K Sindelar; C A Chu; M Rohlie; D W Neal; L L Swift; A D Cherrington
Journal:  Diabetes       Date:  1997-02       Impact factor: 9.461

7.  Direct and indirect effects of insulin to inhibit hepatic glucose output in obese subjects.

Authors:  R Prager; P Wallace; J M Olefsky
Journal:  Diabetes       Date:  1987-05       Impact factor: 9.461

8.  Hepatic glucose production is regulated both by direct hepatic and extrahepatic effects of insulin in humans.

Authors:  G F Lewis; B Zinman; Y Groenewoud; M Vranic; A Giacca
Journal:  Diabetes       Date:  1996-04       Impact factor: 9.461

9.  Exogenous insulin dose-dependently suppresses glucopenia-induced glucagon secretion from perfused rat pancreas.

Authors:  K Ito; H Maruyama; H Hirose; K Kido; K Koyama; K Kataoka; T Saruta
Journal:  Metabolism       Date:  1995-03       Impact factor: 8.694

10.  Evidence that the brain of the conscious dog is insulin sensitive.

Authors:  S N Davis; C Colburn; R Dobbins; S Nadeau; D Neal; P Williams; A D Cherrington
Journal:  J Clin Invest       Date:  1995-02       Impact factor: 14.808

View more
  23 in total

1.  FoxOs function synergistically to promote glucose production.

Authors:  Rebecca A Haeusler; Klaus H Kaestner; Domenico Accili
Journal:  J Biol Chem       Date:  2010-09-29       Impact factor: 5.157

Review 2.  Central nervous system and control of endogenous glucose production.

Authors:  Giovanna Demuro; Silvana Obici
Journal:  Curr Diab Rep       Date:  2006-06       Impact factor: 4.810

3.  Phosphoinositide 3-kinase regulatory subunit p85alpha suppresses insulin action via positive regulation of PTEN.

Authors:  Cullen M Taniguchi; Thien T Tran; Tatsuya Kondo; Ji Luo; Kohjiro Ueki; Lewis C Cantley; C Ronald Kahn
Journal:  Proc Natl Acad Sci U S A       Date:  2006-07-31       Impact factor: 11.205

4.  Physical exercise reduces pyruvate carboxylase (PCB) and contributes to hyperglycemia reduction in obese mice.

Authors:  Vitor Rosetto Muñoz; Rafael Calais Gaspar; Barbara Moreira Crisol; Guilherme Pedron Formigari; Marcella Ramos Sant'Ana; José Diego Botezelli; Rodrigo Stellzer Gaspar; Adelino S R da Silva; Dennys Esper Cintra; Leandro Pereira de Moura; Eduardo Rochete Ropelle; José Rodrigo Pauli
Journal:  J Physiol Sci       Date:  2017-07-14       Impact factor: 2.781

Review 5.  Central nervous system control of metabolism.

Authors:  Martin G Myers; David P Olson
Journal:  Nature       Date:  2012-11-15       Impact factor: 49.962

Review 6.  Mechanisms of Insulin Action and Insulin Resistance.

Authors:  Max C Petersen; Gerald I Shulman
Journal:  Physiol Rev       Date:  2018-10-01       Impact factor: 37.312

Review 7.  FoxO integration of insulin signaling with glucose and lipid metabolism.

Authors:  Sojin Lee; H Henry Dong
Journal:  J Endocrinol       Date:  2017-02-17       Impact factor: 4.286

8.  Adiponectin complexes in human cerebrospinal fluid: distinct complex distribution from serum.

Authors:  C M Kusminski; P G McTernan; T Schraw; K Kos; J P O'Hare; R Ahima; S Kumar; P E Scherer
Journal:  Diabetologia       Date:  2007-01-23       Impact factor: 10.122

9.  Central insulin action regulates peripheral glucose and fat metabolism in mice.

Authors:  Linda Koch; F Thomas Wunderlich; Jost Seibler; A Christine Könner; Brigitte Hampel; Sigrid Irlenbusch; Georg Brabant; C Ronald Kahn; Frieder Schwenk; Jens C Brüning
Journal:  J Clin Invest       Date:  2008-06       Impact factor: 14.808

10.  An explorative study of in vivo digestive starch characteristics and postprandial glucose kinetics of wholemeal wheat bread.

Authors:  Marion G Priebe; Renate E Wachters-Hagedoorn; Janneke A J Heimweg; Alexandra Small; Tom Preston; Henk Elzinga; Frans Stellaard; Roel J Vonk
Journal:  Eur J Nutr       Date:  2008-10-13       Impact factor: 5.614

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.